Keyphrases
Chronic Obstructive Pulmonary Disease
76%
People Living with HIV (PLHIV)
65%
Forced Expiratory Volume in 1 Second (FEV1)
43%
Acute Exacerbation of COPD (AECOPD)
36%
Lung Function
31%
Spirometry
23%
Lung Function Decline
21%
Confidence Interval
21%
Antiretroviral Therapy
20%
AIDS/HIV
20%
Pulmonary Function
19%
Obstructive Sleep Apnea
18%
Smokers
17%
HIV-associated
17%
COPDGene
16%
Hospitalization
16%
Obstructive Lung Disease
15%
Placebo
14%
Multicenter AIDS Cohort Study
13%
HIV-negative
13%
HIV-positive
12%
Emphysema
12%
Forced Vital Capacity
12%
Respiratory Health
12%
Hazard Ratio
12%
HIV Infection
12%
St. George's Respiratory Questionnaire
12%
Comorbidity
11%
Risk Factors
11%
Odds Ratio
11%
Chronic Lung Disease
11%
Airway Obstruction
10%
COVID-19
10%
Lung
10%
Insomnia
9%
Clinical Outcomes
9%
Prospective Cohort Study
9%
Metoprolol
9%
Asthma
9%
Beta-blockers
9%
Vitamin D Status
9%
Strategic Timing
9%
Inhaled Corticosteroids
9%
25-hydroxyvitamin D (25OHD)
8%
Respiratory Symptoms
8%
Severe Chronic Obstructive Pulmonary Disease
8%
High Risk
8%
Health Status
8%
Quality of Life
8%
Acute Respiratory Events
8%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Chronic Obstructive Pulmonary Disease
69%
Lung
51%
Forced Expiratory Volume
29%
Cohort Analysis
27%
Biological Marker
22%
Lung Function
20%
Smoking
19%
Obstructive Sleep Apnea
18%
Antiretroviral Therapy
16%
Spirometry
14%
COVID-19
13%
Human Immunodeficiency Virus Infection
13%
Odds Ratio
13%
Emphysema
12%
Placebo
12%
DLCO
11%
Chronic Lung Disease
10%
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
10%
Quality of Life
9%
Silo-Filler's Disease
9%
Prevalence
8%
Forced Vital Capacity
8%
Airway Obstruction
8%
St. George Respiratory Questionnaire
7%
Infection
7%
Cross Sectional Study
6%
Cardiovascular Disease
6%
Genetic Epidemiology
6%
Interleukin 6
6%
Drive
6%
Coronary Artery
6%
Immunoglobulin
6%
Vitamin D
6%
Systematic Review
6%
Obstructive Lung Disease
6%
Prospective Cohort Study
6%
Diffusing Capacity
5%
Asthma
5%
C Reactive Protein
5%
Comorbidity
5%